Skip to main content

Market Overview

Benzinga's Top #PreMarket Losers


Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 11.32 percent to $89.15 in pre-market after falling 0.24 percent on Tuesday.

Francesca's Holdings Corp (NASDAQ: FRAN) shares fell 5.16 percent to $15.25 in pre-market trading. Francesca's reported Q4 earnings of $0.17 per share on revenue of $95 million. The company expected Q2 earnings of $0.81 to $0.90 per share, on revenue of $104 million to $107 million.

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares declined 3.34 percent to $508.50 in pre-market trading. The FDA Panel has recommended the approval of Sanofi and Regeneron's Praluent.

Gulfport Energy Corporation (NASDAQ: GPOR) shares tumbled 2.82 percent to $44.09 in pre-market trading. Gulfport Energy announced an offering of 10 million common shares.

bluebird bio Inc (NASDAQ: BLUE) fell 2.63 percent to $181.73 in pre-market trading after dropping 1.05 percent on Tuesday.


Related Articles (FRAN + ESPR)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Movers & Shakers Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at